Gilead Sciences (GILD)Banco Santander, S.A. reduced its stake -9,611 shares

266K

Shares reported · -9,611 vs prior quarter

0.21%

Disclosed portfolio weight

$33.7M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
2. May 6, 2026Congress · 1 personMembers of Congress: 2 purchases
3. Jun 1, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
4. Jun 15, 2026Insider · 2 peopleInsiders: 4 sales (~$748K)
5. Jun 24, 2026FDAFDA drug approval: Trodelvy
6. Jun 24, 2026FDAFDA drug approval: Trodelvy
7. Jul 1, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)
8. Jul 15, 2026Insider · 2 peopleInsiders: 2 sales (~$780K)

What came next

1. Aug 3, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
2. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
3. Aug 17, 2026Insider · 2 peopleInsiders: 3 sales (~$4.3M)
4. Aug 20, 2026Insider · 1 personInsiders: 5 sales (~$725K)
5. Aug 26, 2026Insider · 1 personInsiders: 4 sales (~$2.7M)
6. Aug 27, 2026FDAFDA drug approval: Bixlenvo Sunlenca Starter Pack (Copackaged)
7. Aug 27, 2026FDAFDA drug approval: Sunlenca
8. Aug 27, 2026FDAFDA drug approval: Bixlenvo
9. Aug 27, 2026FDAFDA drug approval: Sunlenca
10. Sep 1, 2026Insider · 1 personInsiders: 3 sales (~$2.2M)
11. Sep 15, 2026Insider · 2 peopleInsiders: 4 sales (~$869K)
12. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$2.2M)

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Gilead Sciences

For Gilead Sciences, OQRO holds 28 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 78 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.

How this filing works

• SEC Form 13F

Other disclosures at Gilead Sciences

• SEC Form 4Oct 3, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026

Everything OQRO holds on this company is on its GILD page.